Mucosal Healing at 14 Weeks Predicts better Outcome in Low-dose Infliximab Treatment for Chinese Patients with Active Intestinal Behcet's Disease. (Q51826693)
Jump to navigation
Jump to search
scientific article published in March 2017
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Mucosal Healing at 14 Weeks Predicts better Outcome in Low-dose Infliximab Treatment for Chinese Patients with Active Intestinal Behcet's Disease. |
scientific article published in March 2017 |
Statements
1 reference
Mucosal Healing at 14 Weeks Predicts better Outcome in Low-dose Infliximab Treatment for Chinese Patients with Active Intestinal Behcet's Disease. (English)
1 reference
Jun Zou
1 reference
Da-Nian Ji
1 reference
Yan Shen
1 reference
Jian-Long Guan
1 reference
Song-Bai Zheng
1 reference
1 March 2017
1 reference
47
1 reference
2
1 reference
171-177
1 reference
Identifiers
1 reference